Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 769

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 769
---
30, 2024. As of June 30, 2024, and September 30, 2024, the Company has recorded $205 as a deposit with a CRO for the management of the Company’s 15-patientstudy of REM-001for cutaneous metastatic breast cancer (“CMBC”). 4 Clinical trials grant Effective July 1, 2023, the Company was awarded a $2,000 Small Business Innovation Research grant from the National Institutes of Health (“NIH”) to support the clinical development of REM-001for the treatment of CMBC. The grant will be received in two tranches: approximately $1,250 for the period July 1, 2023, to June 30, 2024, and approximately $750 for the period July 1, 2024, to June 30, 2025. As a result of receiving the grant, the REM-001, 15-patientclinical trial was restarted. The grant is expended to the Company as a reimbursement of expenditures incurred. During the three months ended September 30, 2024, the Company received $236 (2023 - $13)for grants received against research and development expenditures in the period. The grant is subject to various performance conditions and funding risk where the financial conditions of the NIH may change from time to time. The Company recognizes the grant only to the extent there is reasonable assurance the grant will be funded to the Company. 5 Property and equipment, net

| Balance, June 30, 2024      |     | $           
 (thousands) | 674 |   |
|:----------------------------|:----|:------------|----:|:--|
| Depreciation                |     |             | (17 | ) |
| Balance, September 30, 2024 |     |             | 657 |   |

F-38

At September 30, 2024, the total capitalized cost of property and equipment was $879 (June 30, 2024 - $879),of which $499 is not in use. The Company has recognized $17 (2023 - $15) in depreciation expense in the three months ended September 30, 2024, on equipment in use. 6 Accounts payable and accrued liabilities

|                     |     |     |  September 30, 
           2024 
              $ 
 (in thousands) |     |     |       June 30, 
           2024